ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds

March 28, 2003

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996